MS and cognition and APOE: the ongoing conundrum about biomarkers.
Sadovnick
A Dessa
AD
Jacobs
Daniel H
DH
D053327:Apolipoprotein E4 / Q000235:genetics; D001057:Apolipoproteins E / Q000235:genetics*; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D003072:Cognition Disorders / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology; D004252:DNA Mutational Analysis; D004185:Disability Evaluation; D042241:Early Diagnosis; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing / Q000592:standards; D005838:Genotype; D006801:Humans; D009069:Movement Disorders / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D009103:Multiple Sclerosis / Q000150:complications* / Q000235:genetics* / Q000503:physiopathology; D011237:Predictive Value of Tests; D018401:Sample Size; D012680:Sensitivity and Specificity
D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D005819:Genetic Markers